Particle.news
Download on the App Store

Tom Brady Says His Dog Is a Clone as Colossal Biosciences Buys Viagen

The revelation accompanied Colossal Biosciences’ purchase of Viagen Pets and Equine, signaling a broader push to scale pet cloning services.

Overview

  • Brady confirmed Junie was cloned from his late dog Lua using blood collected before Lua’s death, in a process arranged with Colossal Biosciences, a company he backs.
  • Colossal announced it acquired Viagen Pets and Equine, an established pet‑cloning firm known for work with celebrity clients such as Barbra Streisand and Paris Hilton.
  • Brady described Colossal’s method as a non‑invasive blood draw that he says gave his family a “second chance,” framing the move as helpful for grieving owners and conservation goals.
  • Experts note cloned pets are genetic twins rather than the same individual, and reports put typical dog cloning costs in the tens of thousands of dollars, with estimates around $50,000 to $85,000.
  • Colossal promotes de‑extinction projects like dire‑wolf and dodo efforts, though some claims have been disputed by conservation groups including the IUCN.